Saturday 17 October 2026
Export GNLN’s income statement to Excel — free account
Greenlane Holdings, Inc.
GNLN Consumer Defensive Tobacco
Greenlane Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.4 million, down 67.2% from fiscal 2024. In the quarter to June 2026, revenue fell 50.4%, EPS grew 76.2% and free cash flow grew 23.8%, each against the same quarter a year earlier.
2.06
0.18
−8.04%
Follow GNLN
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
1.17 | 2.70 | 3.63 | 3.38 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(1.40) | (2.64) | (2.50) | (4.37) | |
P/B ratio |
0.50 | 0.17 | 0.24 | 0.39 | |
Price to Tangible BV |
0.00 | 0.59 | 5.68 | 0.00 | |
EV/Sales |
1.34 | (4.17) | 0.41 | 2.19 | |
EV/EBITDA |
0.00 | 0.34 | 0.00 | 0.00 | |
EV/Operating CF |
(0.47) | 1.12 | (0.08) | (0.42) | |
EV/FCF |
(0.46) | 0.74 | (0.04) | (0.18) | |
Quick Ratio |
0.90 | 4.73 | 2.97 | 2.16 | |
Current Ratio |
2.17 | 5.01 | 3.25 | 2.36 | |
Net Debt/EBITDA |
0.20 | 0.85 | 2.44 | 1.93 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.18 | 0.08 | 0.07 | 0.09 | |
Operating CF/Net income |
0.44 | 0.06 | 0.26 | 0.09 | |
Capex/Depreciation |
(0.08) | (82.68) | (96.47) | (7.86) | |
Interest Coverage |
(4,550.00) | (38,415.00) | 163.88 | 149.27 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
463.77% | 2,100.00% | 1,264.06% | 894.88% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 1,718.59% | 185.71% | 60.36% | |
Graham Net Nets |
1.42 | 2.46 | 1.14 | 0.90 | |
Graham Number |
13,615.50 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
412,615.46% | (726.98%) | (3,150.59%) | (3,052.79%) | |
Free Cash Flow Yield |
(247.01%) | (208.48%) | (297.73%) | (352.40%) | |
Revenue per Share |
4.25 | 1.45 | 0.11 | 0.10 | |
Operating CF per Share |
(22.53) | (4.76) | (1.18) | (0.55) | |
Capex per Share |
(0.04) | (8.74) | (2.48) | (0.28) | |
Free Cash Flow per Share |
(22.57) | (13.50) | (3.66) | (0.84) | |
Cash per Share |
10.44 | 34.72 | 3.26 | 1.48 | |
Shareholders Equity per Share |
63.51 | 72.32 | 12.25 | 6.22 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
63.51 | 72.32 | 12.25 | 6.22 | |
Free Cash Flow |
(3.91) | (12.64) | (14.96) | (3.43) | |
Working Capital |
7.72 | 28.88 | 13.83 | 8.90 | |
Capital Expenditures |
(0.01) | (8.18) | (10.13) | (1.16) | |
Net Current Asset Value |
7.72 | 28.88 | 13.83 | 8.90 | |
EV/EBIT |
0.00 | 0.33 | 0.00 | 0.00 | |
Capex to Sales |
0.01 | 6.01 | 22.61 | 2.98 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
3.23 | 2.92 | 5.74 | 5.93 | |
Average Payables |
7.48 | 7.60 | 7.63 | 7.36 | |
Average Inventory |
11.13 | — | — | — | |
Average Assets |
25.73 | 51.78 | 47.16 | 31.90 | |
Average Common Equity |
10.17 | 37.00 | 36.62 | 22.71 |
Columns are period end dates